Account
Publications
22.08.2018
Biosimilar market access considerations

Purpose of this study was to understand the EU member state' local market access needs in relation t...

Read more
Publications
23.05.2018
Reducing drug wastage

The aim of this study was to determine the impact of delivery device reducing drug wastage.

Read more
Publications
11.05.2018
ICERs are not all the same

To determine if there is a difference between incremental cost-effectiveness ratios (ICERs) in oncol...

Read more
Publications
08.11.2017
NICE's modified Cancer Drugs Fund process

This study investigates the efficiency of the new CDF appraisal process for indications without prio...

Read more
Publications
24.05.2017
NICE re-evaluation of oncology drugs

This study investigates NICE's evaluation of existing CDF treatments and its potential impact on fun...

Read more
Publications
15.05.2016
ISPOR 2018 Achieving faster product launch

The objective of this research was to determine the national price submission procedures across Euro...

Read more
Publications
05.05.2016
Achieving Fast Product Launch

How to obtain non-reimbursed prices within the EU was presented at ISPOR's 21st annual international...

Read more
Publications
02.03.2016
Achieving faster product launch

We are delighted to announce that our abstract has been accepted for presentation at ISPOR US confer...

Read more
Publications
11.11.2015
ISPOR 2015 Payers' valuation of the cost per month

The aim of this study was to assess the launch price of mCRPC treatments across the EU5 (France, Ger...

Read more
Publications
20.05.2015
ISPOR 2015 Biosimilar pricing and reimbursement

This study determines if EU pricing and reimbursement bodies have revised their pricing and reimburs...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.